Loncar China BioPharma ETF (CHNA)

NASDAQ: CHNA · IEX Real-Time Price · USD
-0.46 (-2.13%)
Jan 31, 2023, 4:00 PM EST - Market closed
Assets $6.34M
Expense Ratio 0.79%
PE Ratio n/a
Shares Out 300,000
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date Dec 29, 2021
Payout Ratio n/a
1-Year Return -6.32%
Volume 3,663
Open 21.25
Previous Close 21.61
Day's Range 19.77 - 21.54
52-Week Low 13.35
52-Week High 22.85
Beta 0.68
Holdings 64
Inception Date Aug 14, 2018

About CHNA

The Loncar China BioPharma ETF (CHNA) is an exchange-traded fund that is based on the Loncar China BioPharma index. The fund tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry. CHNA was launched on Aug 14, 2018 and is managed by Loncar.

Asset Class Equity
Category China Region
Region Asia-Pacific
Stock Exchange NASDAQ
Ticker Symbol CHNA
Issuer Website Loncar
Index Tracked Loncar China BioPharma

Top 10 Holdings

26.55% of assets
Name Symbol Weight
Akeso Inc Ordinary Shares 9926.HK 3.53%
Keymed Biosciences Inc 2162.HK 3.23%
BeiGene, Ltd. BGNE 2.97%
Hangzhou Tigermed Consulting Co Ltd Class H 3347.HK 2.83%
3SBio Inc Shs Unitary 144A/Reg S 1530.HK 2.50%
Luye Pharma Group Ltd 2186.HK 2.42%
Wuxi AppTec Co Ltd 2359.HK 2.36%
CSPC Pharmaceutical Group Ltd 1093.HK 2.26%
HUTCHMED (China) Limited HCM 2.23%
Sino Biopharmaceutical Ltd 1177.HK 2.22%
View More Holdings


Ex-Dividend Amount Pay Date
Dec 29, 2021 $3.03143 Dec 31, 2021
Dec 30, 2020 $0.15462 Jan 4, 2021
Dec 23, 2019 $0.04025 Dec 26, 2019
Full Dividend History


What Lies Ahead for China ETFs in the Year of Rabbit?

The Chinese markets have recently made a comeback. Can the rally last in the year of water rabbit?

1 week ago - Zacks Investment Research

China ETFs Lead the Way in This Week's Top Performing ETFs

This week's top-performing ETFs include five China-focused strategies, a far cry from the panic that China would be uninvestable following the Fall's Chinese Communist Party Congress. Led by the top E...

3 weeks ago - ETF Trends

4 Best Areas of Q4 Up At Least 20% & Their Top ETFs

The fourth quarter of 2022 is just about to wrap up. The broader market has posted mixed performance during this time frame.

Other symbols: DBSEZUIEZ
1 month ago - Zacks Investment Research

5 Best-Performing ETFs of Last Week

Wall Street was downbeat last week on rising rate fears and recessionary concerns.

Other symbols: SARK
2 months ago - Zacks Investment Research

China ETFs Rallying: Top Gainers Past Month

China ETFs have been rallying of late to reflect easing Covid controls and a sweeping rescue package to bail out developers.

2 months ago - Zacks Investment Research

Best Biotech Stocks & ETFs for mRNA, Gene Editing

Here is what you should know about investing in these life changing technologies.

1 year ago - Zacks Investment Research

4 China ETFs Beating S&P 500 in its Worst Week Since 2008

Check these China ETFs that beat the S&P 500 in the past week, which was U.S. equities?

Other symbols: CHICKFYPKWEB
3 years ago - Zacks Investment Research

Best Pharmaceutical ETFs for Q1 2020

The best pharmaceutical ETFs for Q1 2020 are KURE, CHIH, and CHNA.

Other symbols: CHIHKURE
3 years ago - Investopedia

Why These Chinese Sector ETFs Are Crushing S&P 500 in 2019

Policy easing in the Chinese economy, cooling trade tensions with the United States and Beijing's efforts for more urbanization have boosted these sector ETFs in 2019.

4 years ago - Zacks Investment Research